Kevin D. Read

7.2k total citations · 1 hit paper
78 papers, 3.0k citations indexed

About

Kevin D. Read is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Kevin D. Read has authored 78 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Epidemiology, 33 papers in Public Health, Environmental and Occupational Health and 31 papers in Molecular Biology. Recurrent topics in Kevin D. Read's work include Trypanosoma species research and implications (33 papers), Research on Leishmaniasis Studies (25 papers) and Synthesis and Biological Evaluation (16 papers). Kevin D. Read is often cited by papers focused on Trypanosoma species research and implications (33 papers), Research on Leishmaniasis Studies (25 papers) and Synthesis and Biological Evaluation (16 papers). Kevin D. Read collaborates with scholars based in United Kingdom, Switzerland and United States. Kevin D. Read's co-authors include Alan H. Fairlamb, Ian H. Gilbert, Susan Wyllie, Paul G. Wyatt, Suzanne Norval, Manu De Rycker, David Horn, Laste Stojanovski, Stephen Patterson and Leah S. Torrie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

Kevin D. Read

76 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need

2017 306 citations Mark C. Field, David Horn et al. Nature Reviews Microbiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin D. Read United Kingdom	33	1.2k	1.1k	1.0k	816	408	78	3.0k
Christian Sergheraert France	35	1.4k 1.1×	693 0.6×	827 0.8×	1.4k 1.7×	286 0.7×	102	3.4k
David W. Gray United Kingdom	27	962 0.8×	662 0.6×	565 0.6×	392 0.5×	181 0.4×	69	2.9k
Sandra Duffy Australia	30	931 0.7×	228 0.2×	726 0.7×	867 1.1×	194 0.5×	92	2.8k
Marvin J. Meyers United States	27	1.2k 0.9×	370 0.3×	239 0.2×	669 0.8×	338 0.8×	62	3.0k
David M. Shackleford Australia	24	656 0.5×	316 0.3×	326 0.3×	714 0.9×	222 0.5×	64	2.1k
Jianbin Zhang China	26	1.3k 1.1×	828 0.8×	363 0.4×	223 0.3×	248 0.6×	56	2.6k
Gustavo Benaím Venezuela	29	1.0k 0.8×	1.1k 1.0×	914 0.9×	321 0.4×	97 0.2×	90	2.2k
Sandra Gemma Italy	35	1.4k 1.1×	257 0.2×	347 0.3×	1.3k 1.6×	263 0.6×	132	3.4k
Stefania Butini Italy	36	1.6k 1.3×	211 0.2×	284 0.3×	1.4k 1.7×	274 0.7×	140	3.5k
Larry W. Hardy United States	19	1.2k 0.9×	425 0.4×	446 0.4×	316 0.4×	203 0.5×	36	1.7k

Countries citing papers authored by Kevin D. Read

Since Specialization

Citations

This map shows the geographic impact of Kevin D. Read's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin D. Read with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin D. Read more than expected).

Fields of papers citing papers by Kevin D. Read

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin D. Read. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin D. Read. The network helps show where Kevin D. Read may publish in the future.

Co-authorship network of co-authors of Kevin D. Read

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin D. Read. A scholar is included among the top collaborators of Kevin D. Read based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin D. Read. Kevin D. Read is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kocatürk, Nur Mehpare, Jennifer Riley, Hannah J. Maple, et al.. (2025). Discovery of a CNS active GSK3 degrader using orthogonally reactive linker screening. Nature Communications. 16(1). 8857–8857. 1 indexed citations

Kapelyukh, Yury, Charlotte Gabel‐Jensen, Laste Stojanovski, et al.. (2025). Application of a mouse model humanized for cytochrome P450–mediated drug metabolism to predict drug-drug interactions between a peptide and small molecule drugs. Drug Metabolism and Disposition. 53(10). 100153–100153.

MacLeod, Annette, Frederick R. C. Simeons, Jennifer Riley, et al.. (2024). Acceleration of infectious disease drug discovery and development using a humanized model of drug metabolism. Proceedings of the National Academy of Sciences. 121(7). e2315069121–e2315069121. 9 indexed citations

George, Jacob, James D. Chalmers, Colin J. Henderson, et al.. (2024). Use of an extensively humanized mouse model to predict the risk of drug–drug interactions in patients receiving dexamethasone. Journal of Pharmacology and Experimental Therapeutics. 392(2). 100053–100053. 2 indexed citations

Gruber, Franz, Zoe C Johnston, Neil R. Norcross, et al.. (2024). Sperm Toolbox—A selection of small molecules to study human spermatozoa. PLoS ONE. 19(2). e0297666–e0297666. 2 indexed citations

Gruber, Franz, Zoe C Johnston, Neil R. Norcross, et al.. (2022). Compounds enhancing human sperm motility identified using a high-throughput phenotypic screening platform. Human Reproduction. 37(3). 466–475. 5 indexed citations

Amewu, Richard K., Patrick Amoateng, Patrick Kobina Arthur, et al.. (2022). Drug discovery research in Ghana, challenges, current efforts, and the way forward. PLoS neglected tropical diseases. 16(9). e0010645–e0010645. 6 indexed citations

Rycker, Manu De, Susan Wyllie, David Horn, Kevin D. Read, & Ian H. Gilbert. (2022). Author Correction: Anti-trypanosomatid drug discovery: progress and challenges. Nature Reviews Microbiology. 20(11). 702–702. 5 indexed citations

Beauchamp, Erwan, Megan C. Yap, Aishwarya Iyer, et al.. (2020). Targeting N-myristoylation for therapy of B-cell lymphomas. Nature Communications. 11(1). 5348–5348. 50 indexed citations

10.

Giordani, Federica, Daniel Paape, Isabel M. Vincent, et al.. (2020). Veterinary trypanocidal benzoxaboroles are peptidase-activated prodrugs. PLoS Pathogens. 16(11). e1008932–e1008932. 22 indexed citations

11.

Zhang, Shaowei, Michiyo Sakuma, Girdhar Singh Deora, et al.. (2019). A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites. Communications Biology. 2(1). 271–271. 44 indexed citations

12.

Foley, David, C.E. Naylor, G M Wood, et al.. (2019). Discovery of Soft-Drug Topical Tool Modulators of Sphingosine-1-phosphate Receptor 1 (S1PR1). ACS Medicinal Chemistry Letters. 10(3). 341–347. 7 indexed citations

13.

Foley, David, C.E. Naylor, Colin Robinson, et al.. (2018). Discovery of super soft-drug modulators of sphingosine-1-phosphate receptor 1. Bioorganic & Medicinal Chemistry Letters. 28(19). 3255–3259. 19 indexed citations

14.

Harrison, Justin R., Stephen Brand, Victoria Smith, et al.. (2018). A Molecular Hybridization Approach for the Design of Potent, Highly Selective, and Brain-Penetrant N -Myristoyltransferase Inhibitors. Journal of Medicinal Chemistry. 61(18). 8374–8389. 46 indexed citations

15.

Bayliss, Tracy, David A. Robinson, Victoria Smith, et al.. (2017). Design and Synthesis of Brain Penetrant Trypanocidal N-Myristoyltransferase Inhibitors. Journal of Medicinal Chemistry. 60(23). 9790–9806. 16 indexed citations

16.

Wyllie, Susan, Suzanne Norval, Stephen Patterson, et al.. (2016). Activation of Bicyclic Nitro-drugs by a Novel Nitroreductase (NTR2) in Leishmania. PLoS Pathogens. 12(11). e1005971–e1005971. 67 indexed citations

17.

Kaiser, Marcel, Karen L. White, Suzanne Norval, et al.. (2013). Structure–Activity Relationship Studies of Pyrrolone Antimalarial Agents. ChemMedChem. 8(9). 1537–1544. 34 indexed citations

18.

Spinks, Daniel, Leah S. Torrie, Stephen Thompson, et al.. (2011). Design, Synthesis and Biological Evaluation of Trypanosoma brucei Trypanothione Synthetase Inhibitors. ChemMedChem. 7(1). 95–106. 36 indexed citations

19.

Smith, Victoria, Laura A. T. Cleghorn, Andrew Woodland, et al.. (2011). Optimisation of the Anti‐Trypanosoma brucei Activity of the Opioid Agonist U50488. ChemMedChem. 6(10). 1832–1840. 6 indexed citations

20.

Spinks, Daniel, Han B. Ong, Chidochangu P. Mpamhanga, et al.. (2010). Design, Synthesis and Biological Evaluation of Novel Inhibitors of Trypanosoma brucei Pteridine Reductase 1. ChemMedChem. 6(2). 302–308. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact